MoneyWorks4Me

Natural Capsules - Quaterly Results

21 May 2024 Evaluate
The company witnessed a 5.46% growth in the revenue at Rs. 402.00 millions for the quarter ended March 2024 as compared to Rs. 381.20 millions during the year-ago period.The Net Profit of the company slipped to Rs. 16.90 millions from Rs. 33.70 millions, a decline of -49.85% on QoQ basis.Operating profit for the quarter ended March 2024 decreased to 57.70 millions as compared to 76.90 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 402.00 381.20 5.46 1538.10 1728.70 -11.03 1538.10 1728.70 -11.03
Other Income 12.60 8.10 55.56 31.40 10.60 196.23 31.40 10.60 196.23
PBIDT 57.70 76.90 -24.97 239.10 365.00 -34.49 239.10 365.00 -34.49
Interest 13.80 12.70 8.66 49.50 35.60 39.04 49.50 35.60 39.04
PBDT 43.90 64.20 -31.62 189.60 329.40 -42.44 189.60 329.40 -42.44
Depreciation 21.40 18.60 15.05 85.70 72.00 19.03 85.70 72.00 19.03
PBT 22.50 45.60 -50.66 103.90 257.40 -59.63 103.90 257.40 -59.63
TAX 5.60 11.90 -52.94 25.90 65.40 -60.40 25.90 65.40 -60.40
Deferred Tax 2.30 6.40 -64.06 6.20 10.90 -43.12 6.20 10.90 -43.12
PAT 16.90 33.70 -49.85 78.00 192.00 -59.38 78.00 192.00 -59.38
Equity 93.30 92.80 0.54 93.30 92.80 0.54 93.30 92.80 0.54
PBIDTM(%) 14.35 20.17 -28.85 15.55 21.11 -26.38 15.55 21.11 -26.38
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..